2,124 results on '"Roche, Nicolas"'
Search Results
252. Additional file 1 of Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study
253. Belief and adherence to COVID 19-lockdown restrictions in patients with asthma versus other chronic diseases: results from a cross-sectional survey nested in the ComPaRe e-cohort, in France.
254. Effect of an Overground Training Session Versus a Treadmill Training Session on Timed Up and Go in Hemiparetic Patients
255. Belief and adherence to COVID 19-lockdown restrictions in patients with asthma versus other chronic diseases: results from a cross-sectional survey nested in the ComPaRe e-cohort, in France
256. Impact de l’asthme en France sur les comorbidités, la consommation de soins et les coûts dans la cohorte CONSTANCES
257. Single-session training on an ascending treadmill slope: effects on gait parameters in persons with stroke. A pilot study
258. Persistent Nasal Inflammation 5 Months after Acute Anosmia in Patients with COVID-19
259. Burden and Characteristics of Severe Chronic Hypoxemia in a Real-World Cohort of Subjects with COPD
260. Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes
261. Prospective Multicenter Validation of the Detection of ALK Rearrangements of Circulating Tumor Cells for Noninvasive Longitudinal Management of Patients With Advanced NSCLC
262. Spasticity in practice (SPACE): an international non-interventional study of botulinum neurotoxin type A in treatment-naïve subjects with spasticity
263. Influence of the side of brain damage on postural upper-limb control including the scapula in stroke patients
264. 10th European Congress of Chemical Engineering (ECCE10)/3rd European Congress of Applied Biotechnology (ECAB3)/5th European Process Intensification Conference (EPIC5) – Nice, France, September 27-October 1, 2015
265. DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS EXPERIENCING ON-TREATMENT EXACERBATIONS, ON-TREATMENT DEATH, OR PREMATURE STUDY TREATMENT WITHDRAWAL: THE IMPACT TRIAL
266. BENEFIT–RISK PROFILES OF FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) VS UMEC/VI IN PATIENTS WITH COPD: A MARKOV MODEL
267. Reassessing the Evidence Hierarchy in Asthma: Evaluating Comparative Effectiveness
268. Microcalorimetric qualitative analysis of biofilm development in porous media used in wastewater treatment by constructed wetland
269. Should We Change Antibiotic Prophylaxis for Lung Surgery? Postoperative Pneumonia Is the Critical Issue
270. Of: A Simple Empirical Model for Hindered Settling in Activated Sludge Clarifier
271. Bias effects on total dose-induced degradation of bipolar linear microcircuits for switched dose-rate irradiation
272. Development of new methodology to model synergistic effects between TID and ASETs
273. Changes in spinal inhibitory networks induced by furosemide in humans
274. Association of chronic nasal symptoms with dyspnoea and quality-of-life impairment in chronic obstructive pulmonary disease
275. Pneumothorax in Women of Child-Bearing Age: An Update Classification Based on Clinical and Pathologic Findings
276. Quality Standards for Real-World Research. Focus on Observational Database Studies of Comparative Effectiveness
277. Noninvasive ventilation for acute respiratory failure after lung resection: an observational study
278. The use of a dose-rate switching technique to characterize bipolar devices
279. Accelerated irradiation method to study synergy effects in bipolar integrated circuits
280. Clinical Pharmacokinetics and Pharmacodynamics of Desloratadine, Fexofenadine and Levocetirizine: A Comparative Review
281. Real-life association between inhaler technique, patient preference and asthma control in patients with uncontrolled asthma switched to budesonide/formoterol DuoResp® Spiromax® combination.
282. Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
283. From GOLD 0 to Pre-COPD
284. Real-life association between inhaler technique, patient preference and asthma control in patients with uncontrolled asthma switched to budesonide/formoterol DuoResp® Spiromax® combination
285. Informing Healthcare Decisions with Observational Research Assessing Causal Effect. An Official American Thoracic Society Research Statement
286. Feasibility and Ethics
287. Does a Single Gait Training Session Performed Either Overground or on a Treadmill Induce Specific Short-Term Effects on Gait Parameters in Patients with Hemiparesis? A Randomized Controlled Study
288. Review and analysis of the radiation-induced degradation observed for the input bias current of linear integrated circuits
289. Total dose effects on error rates in linear bipolar systems
290. La réutilisation des eaux, une idée simple, une mise en œuvre complexe
291. Systemic Medications in Chronic Obstructive Pulmonary Disease Use and Outcomes
292. In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity
293. No evidence of clinical efficacy of hydroxychloroquine in patients hospitalized for COVID-19 infection with oxygen requirement: results of a study using routinely collected data to emulate a target trial
294. Biological Removal and Fate Assessment of Diclofenac Using Bacillus subtilis and Brevibacillus laterosporus Strains and Ecotoxicological Effects of Diclofenac and 49-Hydroxy-diclofenac
295. Expanding the spectrum of European Respiratory Society official scientific documents: short documents complement clinical practice guidelines, statements and technical standards [editorial]
296. Additional file 1 of Impact of baseline symptoms and health status on COPD exacerbations in the FLAME study
297. Guidance production before evidence generation for critical issues: the example of COVID-19 [editorial]
298. Single-Event Effect Performance of a Commercial ReRAM
299. Radiation Effects of Commercial Resistive Random Access Memories
300. Single-Event Effect Response of a Commercial ReRAM
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.